Senior insider sale
Chief Financial Officer at INDIVIOR PHARMACEUTICALS, INC. — senior position signals high conviction
$1.36M
36K shares
What this filing means
PREBLICK RYAN plans to sell 36K shares of INDIVIOR PHARMACEUTICALS, INC. valued at approximately $1.36M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/8/2026ACC: 0001959173-26-004422
Officer· Chief Financial Officer
Since Mar 2026
36K
Shares to sell
$1.36M
Approx. market value
36K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months3
Restricted Stock Vesting
Compensation
3/9/2023
23.27KRestricted Stock Vesting
Compensation
3/5/2022
6.25KRestricted Stock Vesting
Compensation
11/28/2021
6.48KTotal acquired36K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/9/2023 | Restricted Stock Vesting Compensation | 23.27K | — |
3/5/2022 | Restricted Stock Vesting Compensation | 6.25K | — |
11/28/2021 | Restricted Stock Vesting Compensation | 6.48K | — |
| Total | 36K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
36K
Market value
$1.36M
6/8/2026
Total
Units
36K
Value
$1.36M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/8/2026 | 36K | $1.36M | NASDAQ | Planned |
| Total | 36K | $1.36M | ||